The immunopeptidomic landscape of ovarian carcinomas

Immunotherapies, particularly checkpoint inhibitors, have set off a revolution in cancer therapy by releasing the power of the immune system. However, only little is known about the antigens that are essentially presented on cancer cells, capable of exposing them to immune cells. Large-scale HLA lig...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Proc Natl Acad Sci U S A
Main Authors: Schuster, Heiko, Peper, Janet K., Bösmüller, Hans-Christian, Röhle, Kevin, Backert, Linus, Bilich, Tatjana, Ney, Britta, Löffler, Markus W., Kowalewski, Daniel J., Trautwein, Nico, Rabsteyn, Armin, Engler, Tobias, Braun, Sabine, Haen, Sebastian P., Walz, Juliane S., Schmid-Horch, Barbara, Brucker, Sara Y., Wallwiener, Diethelm, Kohlbacher, Oliver, Fend, Falko, Rammensee, Hans-Georg, Stevanović, Stefan, Staebler, Annette, Wagner, Philipp
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2017
Assuntos:
PNAS Plus
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5699044/
https://ncbi.nlm.nih.gov/pubmed/29093164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1707658114
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados